Accelerating Access to Innovative Therapies for European Patients Through Integrated Decision-Making

Tue, Nov 10, 2026 · 10:00–10:45 AM CET Ecosystem Innovation Stage, Koelnmesse

About this session

Therapeutic breakthroughs are worthless if they do not reach patients. It often takes far too long for innovative therapies to be put into practice. This is because approval, benefit assessment, and pricing are handled by different decision-makers, and decisions are made sequentially rather than in parallel. But what if decision-makers collaborate, pursue a common goal, and make decisions in a single process rather than one after another? Using case studies, this panel examines how the networked collaboration of decision-makers can facilitate the rapid introduction of medicines in Europe.

Speakers

Tilo Mandry

Lead International Liaison Manager · IGES Institut

Moderator
Laurent Goux

Senior VP and General Manager Europe · Krystal Biotech

Panelist
Erwan Gicquel

Government Affairs Lead, Europe · Miltenyi Biomedicine GmbH

Panelist
Tina Taube

Head Strategic Market Access · EFPIA

Panelist
Bettina Ziegele

Liaison Officer Stakeholder Cooperation & International Relations · Paul Ehrlich Institute

Panelist